Middleton & Co’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.99M Buy
45,649
+3,252
+8% +$151K 0.21% 73
2026
Q2
$1.81M Buy
42,397
+18,640
+78% +$1.01M 0.19% 79
2026
Q1
$1.49M Buy
+23,757
New +$1.9M 0.17% 83

Other funds holding BSX

Middleton & Co's BSX Position: Q3 2026 in Review

Middleton & Co increased its Boston Scientific (BSX) stake by 7.7% in Q3 2026, buying an estimated $151K and bringing the position to 45,649 shares worth $1.99M. The position accounts for 0.21% of the portfolio, ranked #73.

Middleton & Co first reported a position in BSX in Q1 2026 and has held it in 3 quarters since. 515 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Middleton & Co held 45,649 shares of Boston Scientific worth $1.99M as of Q3 2026.
  • Middleton & Co bought 3,252 Boston Scientific shares in Q3 2026, an estimated $151K.
  • Boston Scientific made up 0.21% of Middleton & Co's portfolio in Q3 2026, its #73 holding.
  • Middleton & Co first reported a position in Boston Scientific in Q1 2026 and has held it in 3 quarters since.
  • 515 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Middleton & Co's 13F filing for Q3 2026, filed 23 Oct 2026.